文献速递青光眼白内障与屈光手术

小梁微旁路支架联合白内障手术治疗闭角型青光眼合并机制患者的疗效

Efficacy of Cataract Surgery With Trabecular Microbypass Stent Implantation in Combined-Mechanism Angle Closure Glaucoma Patients.
PubMed 文献 · Am J Ophthalmol · 2018-08-08

回顾性队列研究纳入301眼,比较四种手术方案。结果显示,合并机制青光眼(CMG)患者行超声乳化联合iStent植入较单纯超声乳化显著提高1年成功率并减少用药数量,且iStent在CMG与原发性开角型青光眼(POAG)中的效果相当。

要点

  • CMG患者联合iStent后1年成功率为43.7%,高于单纯超声乳化的37.6%。
  • iStent显著减少CMG和POAG患者的降眼压药物数量。
  • iStent在CMG与POAG中的成功率、眼压和用药数量效果相似。

核心结论

  • 超声乳化联合iStent植入较单纯超声乳化显著提高CMG患者1年成功率并减少用药数量。
  • iStent在POAG与CMG中的疗效(成功率、眼压、用药数量)无显著差异。

研究设计与样本

  • 回顾性队列研究,纳入301眼,分为POAG-PE、POAG-PE/iStent、CMG-PE、CMG-PE/iStent四组。
  • CMG定义为虹膜周切后房角开放的窄角型青光眼患者。
  • 采用线性混合效应模型分析iStent对术后1年成功率(眼压≤18 mmHg且无需用药)、眼压和用药数量的影响。

主要发现

  • 1年成功率:POAG-PE组13.1%,POAG-PE/iStent组33.3%(B 3.01;P < .001)。
  • 1年成功率:CMG-PE组37.6%,CMG-PE/iStent组43.7%(B 2.25;P < .001)。
  • POAG-PE与POAG-PE/iStent之间、CMG-PE与CMG-PE/iStent之间眼压无差异。
  • iStent显著减少POAG组用药数量(B -0.70;P < .001)和CMG组用药数量(B -0.52;P < .001)。
  • iStent对POAG和CMG在成功率、眼压和用药数量方面的效果相似(P > .05)。

关键数值与推荐

  • 成功标准:术后1年眼压≤18 mmHg且无需降眼压药物。
  • CMG定义:窄角型青光眼患者虹膜周切后房角开放。

临床怎么用

  • 对于CMG患者,可考虑超声乳化联合iStent植入以提高手术成功率并减少术后用药。
  • iStent在CMG中的疗效与POAG相当,支持其在CMG中的应用。

局限性

  • 回顾性研究设计可能存在选择偏倚和信息偏倚。
  • 随访时间仅1年,长期效果未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the effectiveness of trabecular microbypass stent (iStent) implantation in combined mechanism glaucoma (CMG). DESIGN: Retrospective cohort study. METHODS: We reviewed the medical charts of patients with the following scenarios: (1) primary open-angle glaucoma (POAG) undergoing phacoemulsification (PE), (2) POAG undergoing PE with iStent (POAG-PE/iStent), (3) CMG undergoing PE (CMG-PE), and (4) CMG undergoing PE with iStent (CMG-PE/iStent). CMG was defined as narrow-angle glaucoma patients whose angle had opened after iridotomy. Linear mixed-effects models were performed to determine the effect of iStent on postoperative 1-year success rate (intraocular pressure [IOP] ≤ 18 without medication), IOP, and number of medications. RESULTS: Data from 301 eyes were available. The number of eyes (subjects) was 61 (45) in the POAG-PE, 60 (50) in POAG-PE/iStent, 93 (76) in CMG-PE, and 87 (70) in CMG-PE/iStent group. Success criteria were achieved in 13.1% for POAG-PE, 33.3% for POAG-PE/iStent (POAG-PE vs POAG-PE/iStent B 3.01; P < .001), 37.6% for CMG-PE, and 43.7% for CMG-PE/iStent (CMG-PE vs CMG-PE/iStent B 2.25; P < .001). There was no difference in the IOP between POAG-PE and POAG-PE/iStent, and between CMG-PE and CMG-PE/iStent. The iStent significantly reduced number of medications in the POAG (B -0.70; P < .001) and CMG group (B -0.52; P < .001). Comparing the effect of iStent on POAG and CMG, the analysis showed similar iStent efficacy in terms of the success rate, IOP, and number of medications (P > .05). CONCLUSIONS: Combined PE/iStent significantly increased success rate and reduced number of medications in CMG patients compared to PE alone. The effects of iStent were comparable between POAG and CMG groups.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chansangpetch S, Lau K, Perez CI, et al. Efficacy of Cataract Surgery With Trabecular Microbypass Stent Implantation in Combined-Mechanism Angle Closure Glaucoma Patients. Am J Ophthalmol. 2018. PMID: 30098352. doi:10.1016/j.ajo.2018.08.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。